Apart from HER2 over-expression and amplification, HER2 gene mutation is a distinct entity in lung carcinogenesis with an incidence of 4.8% among EGFR wild-type lung adenocarcinoma resection samples [6]. The gene discussed is ERBB2; the disease is lung adenocarcinoma.